Cherkasy Regional Cardiological Center

Cherkasy 18009

0 studies enrolling now · 2 studies all time

What they study most

Dyslipidemia, Myocardial Infarction, Type2 Diabetes

Studies at this site

• Pemafibrate to Reduce Cardiovascular OutcoMes by Reducing Triglycerides IN patiENts With diabeTes (PROMINENT) — Stopped early
• EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) — Completed